Soluble hemojuvelin in transfused and untransfused thalassaemic subjects

Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Metho...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of haematology Vol. 98; no. 1; pp. 67 - 74
Main Authors Ferro, Elisa, Di Pietro, Angela, Visalli, Giuseppa, Piraino, Basilia, Salpietro, Carmelo, La Rosa, Maria Angela
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.01.2017
Subjects
Online AccessGet full text
ISSN0902-4441
1600-0609
1600-0609
DOI10.1111/ejh.12786

Cover

Abstract Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Method We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Results Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. Conclusion These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.
AbstractList The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia.OBJECTIVEThe hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia.We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis.METHODWe have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis.Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection.RESULTSUntransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection.These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.CONCLUSIONThese results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.
Objective The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Method We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Results Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. Conclusion These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.
The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.
Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin (sHJV) levels could allow for a better understanding of the pathophysiological mechanisms of hepcidin regulation in thalassaemia. Method We have assessed sHJV in 45 transfused and 15 untransfused thalassaemic patients in comparison with 15 healthy subjects, evaluating its relationships with some parameters of iron overload, anaemia and erythropoiesis. Results Untransfused thalassaemic patients had more severe anaemia and erythropoietic activity, while in transfused patients, the transfused RBCs reduced % reticulocytes and sTfR, increased serum indices of iron overload and iron stores in the liver (low MRI T2* values). sHJV levels were higher in patients than in controls and in untransfused in comparison with transfused patients. In the transfused group, we also found that sHJV values are significantly related to serum ferritin, cardiac MRI T2* and growth differentiation factor 15 and are sensitive to hepatitis C virus infection. Conclusion These results suggest that sHJV synthesis seems to be affected by an erythropoietic/hypoxic signal in untransfused patients that have severe anaemia, while in regularly transfused subjects, it is influenced by iron stores.
Author Salpietro, Carmelo
La Rosa, Maria Angela
Di Pietro, Angela
Ferro, Elisa
Visalli, Giuseppa
Piraino, Basilia
Author_xml – sequence: 1
  givenname: Elisa
  orcidid: 0000-0001-9645-4530
  surname: Ferro
  fullname: Ferro, Elisa
  email: ferro_elisa@alice.it
  organization: University Hospital of Messina
– sequence: 2
  givenname: Angela
  surname: Di Pietro
  fullname: Di Pietro, Angela
  organization: University of Messina
– sequence: 3
  givenname: Giuseppa
  surname: Visalli
  fullname: Visalli, Giuseppa
  organization: University of Messina
– sequence: 4
  givenname: Basilia
  surname: Piraino
  fullname: Piraino, Basilia
  organization: University Hospital of Messina
– sequence: 5
  givenname: Carmelo
  surname: Salpietro
  fullname: Salpietro, Carmelo
  organization: University Hospital of Messina
– sequence: 6
  givenname: Maria Angela
  surname: La Rosa
  fullname: La Rosa, Maria Angela
  organization: University Hospital of Messina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27440164$$D View this record in MEDLINE/PubMed
BookMark eNp9kFFLwzAQx4NM3Jw--AWk4Is-dCZpljSPIuoUwQf1OVzTK2tJ29k0it_ezk0RQY-Dg-P3P47fPhk1bYOEHDE6Y0OdY7WcMa5SuUMmTFIaU0n1iEyopjwWQrAx2fe-opRyzdQeGXMlBGVSTMjisXUhcxgtsW6r8IqubKKh-w4aXwSPeQRNHoXmx6JfggPvAevSRj5kFdreH5DdApzHw-2ckufrq6fLRXz_cHN7eXEf22SeyFhRKdLCMmmVBpunDCGxKeq5yFTOdT7PBeMiQRQ6RQGyAA2gM0Gl5QDWJlNyurm76tqXgL43dektOgcNtsEblnKp-JwnbEBPfqFVG7pm-M4wzalQiZJr6nhLhazG3Ky6sobu3Xw5GoCzDWC71vsOi2-EUbP2bwb_5tP_wJ7_Ym3ZQ1-2a3-l-y_xVjp8__u0ubpbbBIfnDiWHw
CitedBy_id crossref_primary_10_1080_10245332_2017_1311462
crossref_primary_10_1186_s12968_020_00627_x
crossref_primary_10_3390_ijms22042204
crossref_primary_10_3390_cancers15041041
Cites_doi 10.1074/jbc.M110.109488
10.1182/blood-2011-01-258467
10.1038/ng1274
10.1016/j.freeradbiomed.2012.08.592
10.1182/blood-2004-06-2422
10.1182/blood-2005-05-1845
10.1186/1471-2407-8-167
10.1182/asheducation-2006.1.29
10.1007/s11255-011-0084-x
10.1074/jbc.M110.173096
10.1182/blood.V96.10.3624
10.1182/blood-2006-06-027631
10.1186/1423-0127-19-83
10.1097/GIM.0b013e3181cd68ed
10.1016/j.bbamcr.2012.01.014
10.1016/j.jhep.2012.06.015
10.1074/jbc.M112.363937
10.1111/j.1365-2141.2007.06728.x
10.1111/ejh.12444
10.1093/clinchem/44.1.40
10.1038/ng.2996
10.1038/nm1629
10.1002/jmri.21781
10.1111/ejh.12122
10.1182/blood-2007-07-100677
10.1182/blood-2008-06-165738
10.1016/j.hoc.2010.08.003
10.1182/blood-2007-09-111567
10.1111/bjh.13815
10.1371/journal.pone.0127518
10.1016/j.bcmd.2012.02.001
10.1007/s00277-009-0879-3
10.1002/hep.22486
10.1182/blood-2012-12-471441
10.2119/2006-00057.Fujita
10.3324/haematol.2010.022129
10.1046/j.1365-2362.2002.0320s1055.x
10.1371/journal.pone.0077267
10.1182/blood-2007-08-109306
10.1074/jbc.273.34.22068
10.1523/JNEUROSCI.4610-03.2004
10.2353/ajpath.2007.060437
10.1038/ng1777
10.1111/ejh.12027
10.1159/000208988
10.1371/journal.pone.0019967
ContentType Journal Article
Copyright 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: Copyright © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7T5
7TM
7TO
H94
K9.
7X8
DOI 10.1111/ejh.12786
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Animal Behavior Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0609
EndPage 74
ExternalDocumentID 27440164
10_1111_ejh_12786
EJH12786
Genre article
Journal Article
GrantInformation_xml – fundername: Regione Sicilia
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EGARE
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
Y6R
YFH
YUY
ZCG
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7T5
7TM
7TO
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3536-70648fc16c79acd81ea3c8e954b7d29d5d41243ee498e4a6fa9aa9b406c2aacc3
IEDL.DBID DR2
ISSN 0902-4441
1600-0609
IngestDate Tue Aug 05 10:53:57 EDT 2025
Wed Aug 13 06:33:21 EDT 2025
Wed Feb 19 01:59:04 EST 2025
Tue Jul 01 04:33:15 EDT 2025
Thu Apr 24 22:53:39 EDT 2025
Wed Jan 22 16:41:10 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords iron overload
hemojuvelin
erythropoiesis
β-thalassaemia
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3536-70648fc16c79acd81ea3c8e954b7d29d5d41243ee498e4a6fa9aa9b406c2aacc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9645-4530
PMID 27440164
PQID 1920473761
PQPubID 2045159
PageCount 8
ParticipantIDs proquest_miscellaneous_1826725231
proquest_journals_1920473761
pubmed_primary_27440164
crossref_primary_10_1111_ejh_12786
crossref_citationtrail_10_1111_ejh_12786
wiley_primary_10_1111_ejh_12786_EJH12786
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2017
2017-01-00
2017-Jan
20170101
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: January 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Hoboken
PublicationTitle European journal of haematology
PublicationTitleAlternate Eur J Haematol
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2010; 12
2006; 91
2012; 287
2004; 104
2011; 117
2012; 1823
2015; 94
2006; 38
2002; 32
2004; 24
2015; 10
2013; 91
2010; 285
2014; 46
2012; 19
2008; 8
2006; 1
2012; 57
2013; 8
2011; 6
2007; 13
2004; 8912
1998; 44
2012; 53
1998; 273
2010; 89
2012; 90
2009; 30
2006; 108
2009; 32
2007; 139
2010; 24
2013; 1221
2007; 170
2000; 96
2005; 106
2008; 48
2015
2010; 173
2012; 48
2008; 112
2008; 111
2009; 1
2012; 44
2004; 436
2010; 95
2011; 286
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
Nemeth E (e_1_2_8_41_1) 2006; 91
e_1_2_8_3_1
Khumalo H (e_1_2_8_37_1) 1998; 44
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_22_1
Tanno T (e_1_2_8_43_1) 2010; 173
e_1_2_8_45_1
e_1_2_8_17_1
Rodriguez Martinez A (e_1_2_8_25_1) 2004; 8912
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_23_1
e_1_2_8_44_1
Aessopos A (e_1_2_8_28_1) 2009; 1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
Centis F (e_1_2_8_42_1) 2000; 96
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_50_1
References_xml – volume: 111
  start-page: 5195
  year: 2008
  end-page: 204
  article-title: Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin
  publication-title: Blood
– volume: 287
  start-page: 35104
  year: 2012
  end-page: 17
  article-title: Neogenin interacts with matriptase‐2 to facilitate hemojuvelin cleavage
  publication-title: J Biol Chem
– volume: 12
  start-page: 61
  year: 2010
  end-page: 76
  article-title: Beta‐thalassaemia
  publication-title: Genet Med
– volume: 111
  start-page: 583
  year: 2008
  end-page: 587
  article-title: Effect of transfusional iron intake on response to chelation therapy in β‐thalassaemia major
  publication-title: Blood
– volume: 1823
  start-page: 1434
  year: 2012
  end-page: 43
  article-title: Hepcidin and iron homeostasis
  publication-title: Biochim Biophys Acta
– volume: 46
  start-page: 678
  year: 2014
  end-page: 84
  article-title: Identification of erythroferrone as an erythroid regulator of iron metabolism
  publication-title: Nat Genet
– volume: 111
  start-page: 924
  year: 2008
  end-page: 31
  article-title: Furin‐mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
  publication-title: Blood
– volume: 112
  start-page: 5241
  year: 2008
  end-page: 4
  article-title: Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anaemia type I
  publication-title: Blood
– volume: 91
  start-page: 74
  year: 2013
  end-page: 84
  article-title: Serum hepcidin levels and muscle iron proteins in humans injected with low‐ or high‐dose erythropoietin
  publication-title: Eur J Haematol
– volume: 19
  start-page: 83
  year: 2012
  article-title: Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter
  publication-title: J Biomed Sci
– volume: 30
  start-page: 62
  year: 2009
  end-page: 8
  article-title: Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron
  publication-title: J Magn Reson Imaging
– volume: 94
  start-page: 404
  year: 2015
  end-page: 12
  article-title: Endocrinopathies metabolic disorders and iron overload in major and intermedia thalassaemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment
  publication-title: Eur J Haematol
– volume: 13
  start-page: 97
  year: 2007
  end-page: 104
  article-title: Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C
  publication-title: Mol Med
– volume: 8912
  start-page: 1441
  year: 2004
  end-page: 5
  article-title: Hepatic and extrahepatic expression of the new iron regulatory protein Hemojuvelin
  publication-title: Haematologica
– volume: 1
  start-page: 29
  year: 2006
  end-page: 39
  article-title: Hepcidin and its role in regulating systemic iron metabolism
  publication-title: Hematology Am Soc Hematol Educ Program
– volume: 285
  start-page: 16416
  year: 2010
  end-page: 23
  article-title: The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein‐6 and hepcidin expression
  publication-title: J Biol Chem
– volume: 10
  start-page: e0127518
  year: 2015
  article-title: Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma
  publication-title: PLoS One
– volume: 117
  start-page: 4425
  year: 2011
  end-page: 33
  article-title: Hepcidin and iron regulation 10 years later
  publication-title: Blood
– volume: 106
  start-page: 2884
  year: 2005
  end-page: 9
  article-title: Competitive regulation of hepcidin mRNA by soluble and cell‐associated hemojuvelin
  publication-title: Blood
– year: 2015
  article-title: HIF1α and Glut1 receptor in transfused and untransfused thalassemic patients
  publication-title: Brit J Haematol
– volume: 96
  start-page: 3624
  year: 2000
  end-page: 9
  article-title: The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta‐thalassaemia major
  publication-title: Blood
– volume: 32
  start-page: 55
  year: 2002
  end-page: 60
  article-title: Oxidative status and malondialdehyde in b‐thalassaemia patients
  publication-title: Eur J Clin Invest
– volume: 48
  start-page: 233
  year: 2012
  end-page: 7
  article-title: Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy
  publication-title: Blood Cells Mol Dis
– volume: 286
  start-page: 4090
  year: 2011
  end-page: 7
  article-title: Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia‐inducible factors: new link between hypoxia signaling and iron homeostasis
  publication-title: J Biol Chem
– volume: 95
  start-page: 2031
  year: 2010
  end-page: 7
  article-title: Immunoassay for human serum Hemojuvelin
  publication-title: Haematologica
– volume: 13
  start-page: 1096
  year: 2007
  end-page: 101
  article-title: High levels of GDF15 in thalassaemia suppress expression of the iron regulatory protein hepcidin
  publication-title: Nat Med
– volume: 89
  start-page: 585
  year: 2010
  end-page: 9
  article-title: Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassaemia intermedia: an MRI T2* study
  publication-title: Ann Hematol
– volume: 139
  start-page: 138
  year: 2007
  end-page: 47
  article-title: Different regulatory elements are required for response of hepcidin to interleukin‐6 and bone morphogenetic proteins 4 and 9
  publication-title: Brit J Haematol
– volume: 108
  start-page: 3204
  year: 2006
  end-page: 9
  article-title: Interleukin‐6 induces hepcidin expression through STAT3
  publication-title: Blood
– volume: 90
  start-page: 31
  year: 2012
  end-page: 6
  article-title: High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anaemia type I
  publication-title: Eur J Haematol
– volume: 173
  start-page: 184
  year: 2010
  end-page: 90
  article-title: Growth differentiation factor 15 in erythroid health and disease
  publication-title: Curr Opin Hematol
– volume: 48
  start-page: 1420
  year: 2008
  end-page: 9
  article-title: Hepatitis C virus‐induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity
  publication-title: Hepatology
– volume: 24
  start-page: 808
  year: 2004
  end-page: 18
  article-title: Repulsive guidance molecule RGM gene function is required for neural tube closure but not retinal to pography in the mouse visual system
  publication-title: J Neurosci
– volume: 1221
  start-page: 124
  year: 2013
  end-page: 33
  article-title: Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β‐thalassaemia major: a longitudinal study
  publication-title: Blood
– volume: 44
  start-page: 1805
  year: 2012
  end-page: 11
  article-title: Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?
  publication-title: Int Urol Nephr
– volume: 6
  start-page: e19967
  year: 2011
  article-title: Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma‐related genes
  publication-title: PLoS One
– volume: 24
  start-page: 1089
  year: 2010
  end-page: 107
  article-title: Anaemia ineffective erythropoiesis and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β‐thalassaemia
  publication-title: Hematol Onc Clin North Am
– volume: 8
  start-page: 167
  year: 2008
  article-title: Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma
  publication-title: BMC Cancer
– volume: 104
  start-page: 4308
  year: 2004
  end-page: 10
  article-title: Expression of Rgmc the murine ortholog of hemojuvelin gene is modulated by development and inflammation but not by iron status or erythropoietin
  publication-title: Blood
– volume: 38
  start-page: 531
  year: 2006
  end-page: 9
  article-title: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
  publication-title: Nat Genet
– volume: 1
  start-page: 2009002
  year: 2009
  article-title: Cardiac function and iron chelation in thalassaemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management
  publication-title: Mediterr J Hematol Infect Dis
– volume: 53
  start-page: 1829
  year: 2012
  end-page: 37
  article-title: Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassaemic subjects
  publication-title: Free Radic Biol Med
– volume: 170
  start-page: 497
  year: 2007
  end-page: 504
  article-title: Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor‐alpha
  publication-title: Am J Pathol
– volume: 91
  start-page: 727
  year: 2006
  end-page: 32
  article-title: Hepcidin and iron‐loading anaemias
  publication-title: Haematologica
– volume: 44
  start-page: 40
  year: 1998
  end-page: 4
  article-title: Gangaidzo IT‐ Serum transferrin receptors are decreased in the presence of iron overload
  publication-title: Clin Chem
– volume: 57
  start-page: 1052
  year: 2012
  end-page: 60
  article-title: The hemochromatosis proteins HFE TfR2 and HJV form a membrane‐associated protein complex for hepcidin regulation
  publication-title: J Hepatol
– volume: 273
  start-page: 22068
  year: 1998
  end-page: 74
  article-title: Co‐trafficking of HFE a nonclassical major histocompatibility complex class I protein with the transferrin receptor implies a role in intracellular iron regulation
  publication-title: J Biol Chem
– volume: 8
  start-page: 77267
  year: 2013
  article-title: proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 Tfr2 do not interact
  publication-title: PLoS One
– volume: 32
  start-page: 71
  year: 2009
  end-page: 6
  article-title: Hemojuvelin: the hepcidin story continues
  publication-title: Kidney Blood Press Res
– volume: 436
  start-page: 77
  year: 2004
  end-page: 82
  article-title: Mutations in HFE2 cause iron overload in chromosome 1q‐linked juvenile hemochromatosis
  publication-title: Nat Genet
– ident: e_1_2_8_6_1
  doi: 10.1074/jbc.M110.109488
– ident: e_1_2_8_5_1
  doi: 10.1182/blood-2011-01-258467
– ident: e_1_2_8_30_1
  doi: 10.1038/ng1274
– ident: e_1_2_8_51_1
  doi: 10.1016/j.freeradbiomed.2012.08.592
– ident: e_1_2_8_44_1
  doi: 10.1182/blood-2004-06-2422
– ident: e_1_2_8_9_1
  doi: 10.1182/blood-2005-05-1845
– ident: e_1_2_8_48_1
  doi: 10.1186/1471-2407-8-167
– ident: e_1_2_8_3_1
  doi: 10.1182/asheducation-2006.1.29
– ident: e_1_2_8_24_1
  doi: 10.1007/s11255-011-0084-x
– ident: e_1_2_8_10_1
  doi: 10.1074/jbc.M110.173096
– volume: 96
  start-page: 3624
  year: 2000
  ident: e_1_2_8_42_1
  article-title: The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta‐thalassaemia major
  publication-title: Blood
  doi: 10.1182/blood.V96.10.3624
– ident: e_1_2_8_18_1
  doi: 10.1182/blood-2006-06-027631
– ident: e_1_2_8_20_1
  doi: 10.1186/1423-0127-19-83
– ident: e_1_2_8_2_1
  doi: 10.1097/GIM.0b013e3181cd68ed
– ident: e_1_2_8_4_1
  doi: 10.1016/j.bbamcr.2012.01.014
– ident: e_1_2_8_13_1
  doi: 10.1016/j.jhep.2012.06.015
– ident: e_1_2_8_31_1
  doi: 10.1074/jbc.M112.363937
– ident: e_1_2_8_19_1
  doi: 10.1111/j.1365-2141.2007.06728.x
– ident: e_1_2_8_33_1
  doi: 10.1111/ejh.12444
– volume: 91
  start-page: 727
  year: 2006
  ident: e_1_2_8_41_1
  article-title: Hepcidin and iron‐loading anaemias
  publication-title: Haematologica
– volume: 44
  start-page: 40
  year: 1998
  ident: e_1_2_8_37_1
  article-title: Gangaidzo IT‐ Serum transferrin receptors are decreased in the presence of iron overload
  publication-title: Clin Chem
  doi: 10.1093/clinchem/44.1.40
– ident: e_1_2_8_17_1
  doi: 10.1038/ng.2996
– ident: e_1_2_8_16_1
  doi: 10.1038/nm1629
– ident: e_1_2_8_27_1
  doi: 10.1002/jmri.21781
– ident: e_1_2_8_15_1
  doi: 10.1111/ejh.12122
– volume: 173
  start-page: 184
  year: 2010
  ident: e_1_2_8_43_1
  article-title: Growth differentiation factor 15 in erythroid health and disease
  publication-title: Curr Opin Hematol
– ident: e_1_2_8_11_1
  doi: 10.1182/blood-2007-07-100677
– ident: e_1_2_8_39_1
  doi: 10.1182/blood-2008-06-165738
– ident: e_1_2_8_40_1
  doi: 10.1016/j.hoc.2010.08.003
– ident: e_1_2_8_29_1
  doi: 10.1182/blood-2007-09-111567
– volume: 8912
  start-page: 1441
  year: 2004
  ident: e_1_2_8_25_1
  article-title: Hepatic and extrahepatic expression of the new iron regulatory protein Hemojuvelin
  publication-title: Haematologica
– ident: e_1_2_8_35_1
  doi: 10.1111/bjh.13815
– ident: e_1_2_8_46_1
  doi: 10.1371/journal.pone.0127518
– ident: e_1_2_8_23_1
  doi: 10.1016/j.bcmd.2012.02.001
– ident: e_1_2_8_32_1
  doi: 10.1007/s00277-009-0879-3
– ident: e_1_2_8_50_1
  doi: 10.1002/hep.22486
– ident: e_1_2_8_36_1
  doi: 10.1182/blood-2012-12-471441
– ident: e_1_2_8_49_1
  doi: 10.2119/2006-00057.Fujita
– ident: e_1_2_8_21_1
  doi: 10.3324/haematol.2010.022129
– ident: e_1_2_8_34_1
  doi: 10.1046/j.1365-2362.2002.0320s1055.x
– ident: e_1_2_8_14_1
  doi: 10.1371/journal.pone.0077267
– ident: e_1_2_8_26_1
  doi: 10.1182/blood-2007-08-109306
– ident: e_1_2_8_12_1
  doi: 10.1074/jbc.273.34.22068
– ident: e_1_2_8_38_1
  doi: 10.1523/JNEUROSCI.4610-03.2004
– ident: e_1_2_8_45_1
  doi: 10.2353/ajpath.2007.060437
– ident: e_1_2_8_8_1
  doi: 10.1038/ng1777
– ident: e_1_2_8_22_1
  doi: 10.1111/ejh.12027
– volume: 1
  start-page: 2009002
  year: 2009
  ident: e_1_2_8_28_1
  article-title: Cardiac function and iron chelation in thalassaemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management
  publication-title: Mediterr J Hematol Infect Dis
– ident: e_1_2_8_7_1
  doi: 10.1159/000208988
– ident: e_1_2_8_47_1
  doi: 10.1371/journal.pone.0019967
SSID ssj0002917
Score 2.1600409
Snippet Objective The hemojuvelin‐bone morphogenetic protein axis is the principal iron‐dependent mechanism of hepcidin regulation. The determination of soluble...
The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble hemojuvelin...
Objective The hemojuvelin-bone morphogenetic protein axis is the principal iron-dependent mechanism of hepcidin regulation. The determination of soluble...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 67
SubjectTerms Adult
Anemia
Biomarkers
Blood diseases
Blood Transfusion
Case-Control Studies
Erythrocyte Indices
Erythropoiesis
Female
Ferritin
GPI-Linked Proteins - blood
Heart diseases
hemojuvelin
Hepatitis C
Hepcidin
Hepcidins - blood
Humans
Hypoxia
Iron
iron overload
Iron Overload - etiology
Liver
Magnetic resonance imaging
Male
Middle Aged
Reticulocytes
Thalassemia - blood
Thalassemia - complications
Thalassemia - therapy
Young Adult
β‐thalassaemia
Title Soluble hemojuvelin in transfused and untransfused thalassaemic subjects
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fejh.12786
https://www.ncbi.nlm.nih.gov/pubmed/27440164
https://www.proquest.com/docview/1920473761
https://www.proquest.com/docview/1826725231
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4yB_HivowbVTx46TBN0yV4Ep1hEPQgDsxBKEn6yjCOHbGtB3-9L-nijAuI0EOX1ybNy0u-vLx8IeQMYhr6HALb6zrKZoJKW1IhbcfHtjCJgbnGoX975w-G7GbkjZbIRb0WpuSHaBxu2jJMe60NXMhszshhMu44NAg13bbj-po3__r-kzqKcrPbrg47tBn2-RWrkI7iad5c7Iu-AcxFvGo6nP4aeayzWsaZPHWKXHbU-xcWx3_-yzpZrYCodVnWnA2yBOkmWb6tptq3yEA7zOQUrDE8zybFm163buGRG6RbZBBbIo2tIp27kY_1qsxM6IB7Kyuk9vFk22TY7z1cDexq2wVbuZ7r2wGilDBRjq8CLlQcOiBcFQL3mAxiymMv1jtWuwCMh8CEnwguBJeIDBQVQil3h7TSWQp7xHKE1_WBBYlIOEOowsGVHC8lBw-_yNvkvFZApCpOcr01xjSqxyZYMpEpmTY5bURfSiKOn4QOay1GlS1mEWLYLguwIXXa5KR5jFakp0ZECrMCZXCUFVAclKPMbqn9JhXDoYijSsys0eHvyUe9m4E52f-76AFZoRopGK_OIWnlrwUcIc7J5bGp0B-xS_iD
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkAqXQkuhCwtNKw69ZLVxnIclLlULSinLoQKJC4psZ6LVQrNVk_TQX9-x8-hSQEJIOeQxiR2Px_5mPJ4BOMSMxaHAyA3Gnna5ZMpVTCrXC2kszDPkvjXoT87D5JKfXgVXS3DU7YVp4kP0BjcjGXa8NgJuDNILUo6z6chjURwuwyonoGFUry_f_wWPYsLm2zWOhy6nWb-NK2T8ePpX785G9yDmXcRqp5yTDbjuKtt4mtyM6kqN9J__4jg-92824WWLRZ1PTed5BUtYvIYXk3a1fQsSYzNTt-hM8cd8Vv82W9cdOioLdusSM0cWmVMXCzeqqdmYWUrjc--UtTJmnvINXJ4cX3xO3Dbzgqv9wA_diIBKnGsv1JGQOos9lL6OUQRcRRkTWZCZpNU-IhcxchnmUkgpFIEDzaTU2t-GlWJe4FtwPBmMQ-RRLnPBCa0I9JWgSyUwoC-KAXzsOJDqNiy5yY5xm3bqCbVMaltmAB960p9NLI6HiIYdG9NWHMuUYOyYRzSWegN43z8mQTKrI7LAeU00pGhFjPRyotlp2N-XYsMokmJJlbVMfLz49Pg0sSe7Tyd9B2vJxeQsPft6_m0P1pkBDtbIM4SV6leN-wR7KnVge_dfPqj8og
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKqFegLYUltI2rXrgktXGcZxYnBBltaUFVVWROFSK_JhoxSOLSMKBX9-x8yj0IVWVcshjEjsej_3NeDwD8B4ty4TENEwmkQm5YjrUTOkwEjQWFhZ57A36xydidsqPzpKzJdjr98K08SEGg5uTDD9eOwG_tsU9Icfz-ThiaSYewWMuCEk4RPT1Z-woJn26Xed3GHKa9LuwQs6NZ3j14WT0G8J8CFj9jDNdg-99XVtHk4txU-uxufsljON__sw6rHZINNhvu85TWMLyGawcd2vtz2HmLGb6EoM5Xi3Om1u3cT2go_ZQt6nQBqq0QVPeu1HP3bbMSjmP-6BqtDPyVBtwOj38djALu7wLoYmTWIQpwZSsMJEwqVTGZhGq2GQoE65Ty6RNrEtZHSNymSFXolBSKakJGhimlDHxC1guFyVuQRCpZCKQp4UqJCesIjHWki61xIS-KEew2zMgN11Qcpcb4zLvlRNqmdy3zAjeDaTXbSSOPxHt9FzMO2GscgKxE57SSBqN4O3wmMTIrY2oEhcN0ZCalTLSyolms-X-UIoPokhqJVXW8_DvxeeHRzN_sv3vpG9g5cuHaf7548mnl_CEOdTgLTw7sFzfNPiKME-tX_u-_QNQtPtR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+hemojuvelin+in+transfused+and+untransfused+thalassaemic+subjects&rft.jtitle=European+journal+of+haematology&rft.au=Ferro%2C+Elisa&rft.au=Di+Pietro%2C+Angela&rft.au=Visalli%2C+Giuseppa&rft.au=Piraino%2C+Basilia&rft.date=2017-01-01&rft.issn=1600-0609&rft.eissn=1600-0609&rft.volume=98&rft.issue=1&rft.spage=67&rft_id=info:doi/10.1111%2Fejh.12786&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0902-4441&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0902-4441&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0902-4441&client=summon